Form 4: National Health Investors CFO Acquires Shares and Stock Options
SEC Form 4 Filing
John L. Spaid, CFO of National Health Investors, reports acquisition of common stock and stock options.
Summary
- John L. Spaid, the CFO/EVP Finance of National Health Investors Inc. (NHI), filed a Form 4 detailing changes in beneficial ownership.
- On March 3, 2025, Spaid acquired 6,500 shares of common stock at $0 and was granted multiple stock option tranches.
- Spaid now beneficially owns 44,682.6372 shares of common stock following the reported transactions.
- The stock options acquired on March 3, 2025, are for 15,000 shares each, with exercise prices of $73.34 and expire on March 3, 2030, vesting annually from March 3, 2026, March 3, 2027 and March 3, 2028.
- Spaid also holds other stock options from previous years.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and stock options by the CFO suggests confidence in the company, but it's a routine disclosure.
Positives
- The acquisition of shares and stock options by a key executive could be interpreted as a positive signal about the executive's confidence in the company's future prospects.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions. They are closely watched by investors for signals about management's view of the company's prospects.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock to align management's interests with those of shareholders.
- The vesting schedules and exercise prices are typical components of such compensation plans.
- Comparing the size of the grants and the exercise prices to those of peer companies would provide a better understanding of the competitiveness of NHI's executive compensation.
Stakeholder Impact
- The transactions could have a minor positive impact on shareholder sentiment if interpreted as a sign of management's confidence.
Key Dates
| Date | Description |
|---|---|
| 02/23/2025 | Date of stock option grant with exercisable date 02/23/2025. |
| 02/24/2025 | Date of stock option grant with exercisable date 02/24/2025. |
| 03/03/2025 | Date of transaction: Acquisition of common stock and stock options. |
| 03/03/2026 | Date of first vesting anniversary for restricted stock. |
| 02/23/2026 | Date of stock option grant with exercisable date 02/23/2026. |
| 03/03/2027 | Date of second vesting anniversary for restricted stock. |
| 02/24/2028 | Date of stock option grant with exercisable date 02/24/2028. |
| 03/03/2028 | Date of third vesting anniversary for restricted stock. |
| 02/23/2029 | Expiration date of stock options granted in 2024. |
| 03/03/2030 | Expiration date of stock options granted in 2025. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.